All COVID-19 articles
-
NewsNIH awards $57.5m to strengthen emerging infectious disease research
Boston University’s high-containment infectious disease laboratory has received $57.5 million in new federal funding to strengthen research on emerging pathogens. The five-year award will support work on vaccines, diagnostics and treatments for threats including Ebola, Marburg, dengue and other high-risk viruses.
-
NewsWastewater bacteria could offer a window into community health
Wastewater may reveal much more about a community than which viruses are circulating. Researchers found that gut-associated bacterial patterns in sewage were linked with rates of chronic disease, health behaviours and socioeconomic conditions across several Ohio communities.
-
NewsQ&A: How do infections get past the placenta’s defenses?
For nine months, the placenta is the primary support system of the fetus, providing both nourishment and protection. Within hours of birth, it is usually discarded as medical waste. But this organ carries clues for the child’s future health and additional pregnancies for the mother.
-
NewsNew AI method spots outbreak signals in sparse and noisy data
A new early-warning method could help detect disease outbreaks even when case data are sparse, delayed or incomplete. By using topological data analysis to capture the underlying shape of epidemic time series, the system remained accurate even when up to half of the surveillance data were missing.
-
NewsHalf of long COVID patients see meaningful symptom improvement within three years
A prospective cohort study found that about half of people living with long COVID a year after their initial COVID-19 infection experienced a meaningful symptom improvement within three years, whereas a quarter experienced a complete remission.
-
NewsRNA-protein interactions could lead to new coronavirus drug targets
A study has identified new targets for coronavirus antiviral drugs, including treatments that may be less vulnerable to the rapid evolution of these viruses. The research mapped previously unknown interactions across the SARS-CoV-2 genome between RNA and proteins involved in the virus’s replication and regulation.
-
NewsNeedle-free approach could offer a new way to deliver mRNA vaccines
A needle-free mRNA vaccine delivered through the skin protected mice against both SARS-CoV-2 and influenza while causing less inflammation than lipid-based formulations. The approach uses a high-pressure liquid jet and a combination of two immune-boosting adjuvants to strengthen protection without relying on conventional mRNA carriers.
-
News‘Raman barcodes’ can distinguish 20 SARS-CoV-2 variants
Viruses may carry a molecular ‘barcode’ hidden not just in their genetic sequence, but in the way their RNA folds and vibrates. Researchers have used Raman spectroscopy to distinguish 20 SARS-CoV-2 variants and subvariants, pointing towards a potentially faster way to screen emerging viral strains.
-
NewsSpouses mattered more than genes for the risk of severe COVID-19
Researchers ound no evidence that genetic factors played an important role in determining who was hospitalised with COVID-19. Instead, spouses of hospitalised individuals had more than three times the risk of being hospitalised themselves compared with matched controls.
-
NewsVaccination has little impact on post-COVID smell and taste issues
Researchers examining whether COVID-19 vaccination affects persistent smell or taste problems after contracting the virus have found that, in most cases, it does not.
-
NewsPlague never disappeared, but modern medicine has changed the risk
Plague may sound like a disease from the history books, but Yersinia pestis still circulates in wildlife around the world. Despite recent concern over a possible laboratory-linked death in Russia, experts stress that human cases remain rare and the infection is usually treatable when diagnosed quickly.
-
NewsA new generation of mRNA antibody therapies may tackle ever-evolving SARS-CoV-2 variants
Researchers have fashioned an advanced antibody therapy that can neutralize SARS-CoV-2 while constraining the virus’ ability to escape recognition. The therapy protected mice against infections with an immune-evasive Omicron variant, and provides a structural template for antiviral antibodies that can keep up with their constantly evolving viral targets.
-
NewsAn approach for novel antiviral compound discovery
Researchers in India have used an AI-based molecule generation platform to design a novel compound that computationally blocks one of the most conserved and functionally essential enzymes of SARS-CoV-2 — the main protease — with drug-like properties, no predicted toxicity, and a binding profile that compares favourably with clinically studied inhibitors.
-
NewsPeople with long Covid have drastically different microbiome in their lungs and mouth
A study of more than 700 people has shown that those with long Covid have distinct differences in the mix of bacteria that live in their mouths and lungs, according to a study. The research also shows that these differences in the lung microbiome are linked to respiratory symptoms, as well as the cognitive and digestive problems known to occur in long Covid.
-
NewsValue-aligned messages increased COVID-19 vaccination intentions, study finds
Vaccine-hesitant adults were more likely to consider getting a COVID-19 vaccine when public health messages acknowledged distrust of government and affirmed values such as personal liberty, a new study found.
-
NewsResearchers built a low-cost system that knows when coughing is on the rise
What if a room could tell when coughing is on the rise without cameras or identifying anyone? Researchers have developed a low-cost sensor system that uses microphones, AI and lightweight computing to count coughs and distinguish between different coughers, potentially helping hospitals spot increases in respiratory illness earlier.
-
NewsScientists identify gene signatures in children with severe COVID-19 infection
Researchers have identified patterns of gene activity associated with severe COVID-19 in children that are shared with other serious respiratory infections. They discovered ten groups of genes which were expressed in a similar pattern across the different lower respiratory tract infections.
-
NewsStudy examines political differences in perceptions of vaccine safety and effectiveness
Vaccine perceptions can influence acceptance and uptake, according to a new study. Respondents perceived the measles, mumps, and rubella vaccine as the safest and most effective and the COVID-19 vaccine as the least safe and effective.
-
NewsCOVID-19 immunity may help protect against other bat coronaviruses
Scientists have found that bat coronaviruses most likely to infect a wide range of animal species are those most closely related to SARS-CoV-2 and most likely to be recognised by immunity generated through COVID-19 infection.
-
NewsViral infections can accelerate the progression of ALS, researchers find
A new study suggests that common viral infections — like influenza or COVID-19 — may accelerate the onset and progression of amyotrophic lateral sclerosis, or ALS. The findings suggest that it is the immune response triggered by these infections that accelerates the onset and progression of ALS.